XML 33 R14.htm IDEA: XBRL DOCUMENT

Share-based compensation

6 Months Ended

Jun. 30, 2021

8Share-based compensation

The Company’s share-based compensation plans include the 2014 Amended and Restated Share Option Plan (the “2014 Plan”) and inducement grants under Rule 5653(c)(4) of the Nasdaq Global Select Market with terms similar to the 2014 Plan (together the “2014 Plans”). At the annual general meeting of shareholders in June 2021, the Company’s shareholders approved amendments of the 2014 Plan, increasing the shares authorized for issuance by 4,000,000 to a total of 12,601,471.

2014 Plans

Share-based compensation expense recognized by classification included in the Consolidated statements of operations and comprehensive loss in relation to the 2014 Plans for the periods indicated below was as follows:


	Three months ended June 30,				Six months ended June 30,
	2021		2020		2021		2020

	(in thousands)				(in thousands)
Research and development	$	3,286	$	2,889	$	5,960	$	5,271
Selling, general and administrative		3,735		2,825		6,815		4,783
Total	$	7,021	$	5,714	$	12,775	$	10,054

Share-based compensation expense recognized by award type was as follows:


	Three months ended June 30,				Six months ended June 30,
	2021		2020		2021		2020

	(in thousands)				(in thousands)
Award type
Share options	$	3,350	$	2,746	$	6,190	$	4,954
Restricted share units		3,222		2,209		5,782		3,653
Performance share units		449		759		803		1,447
Total	$	7,021	$	5,714	$	12,775	$	10,054

As of June 30, 2021, the unrecognized share-based compensation expense related to unvested awards under the 2014 Plans were:


	Unrecognized		Weighted average
	share-based		remaining
	compensation		period for
	expense		recognition
	(in thousands)		(in years)
Award type
Share options	$	34,855	2.99
Restricted share units		24,960	2.25
Performance share units		792	0.58
Total	$	60,607	2.66

The Company satisfies the exercise of share options and vesting of Restricted Share Units (“RSUs”) and Performance Share Units (“PSUs”) through newly issued ordinary shares.

Share options

Share options are priced on the date of grant and, except for certain grants made to non-executive directors, vest over a period of four years. The first 25% vests after one year from the initial grant date and the remainder vests in equal quarterly installments over years two, three and four. Certain grants to non-executive directors vest in full after one year. Any options that vest must be exercised by the tenth anniversary of the initial grant date.

The following tables summarize option activity under the Company’s 2014 Plans for the six months ended June 30, 2021:


	Options
	Number of	Weighted average
	ordinary shares	exercise price

Outstanding at December 31, 2020	2,659,279	$	28.13
Granted	914,118	$	36.36
Forfeited	(74,397)	$	43.19
Expired	(9,093)	$	44.14
Exercised	(71,976)	$	12.65
Outstanding at June 30, 2021	3,417,931	$	30.29
Thereof, fully vested and exercisable at June 30, 2021	1,774,059	$	21.68
Thereof, outstanding and expected to vest after June 30, 2021	1,643,872	$	39.58


Total weighted average grant date fair value of options issued during the period (in $ millions)	$	19.4
Proceeds from option sales during the period (in $ millions)	$	0.9

The fair value of each option issued is estimated at the respective grant date using the Hull & White option pricing model with the following weighted-average assumptions:


	Three months ended June 30,		Six months ended June 30,
Assumptions	2021	2020	2021	2020
Expected volatility	75%	70%	75%	70%
Expected terms	10 years	10 years	10 years	10 years
Risk free interest rate	1.72% - 1.85%	0.76% - 0.83%	1.21% - 1.85%	0.76% - 1.44%
Expected dividend yield	0%	0%	0%	0%

Restricted share units (“RSUs”)

The following table summarizes the RSUs activity for the six months ended June 30, 2021:


	RSU
		Weighted average
	Number of	grant-date fair
	ordinary shares	value
Non-vested at December 31, 2020	467,344	$	43.56
Granted	481,821	$	36.50
Vested	(145,203)	$	39.89
Forfeited	(31,067)	$	42.86
Non-vested at June 30, 2021	772,895	$	39.87

Total weighted average grant date fair value of RSUs granted during the period (in $ millions)		$	17.6

RSUs vest over one to three years. RSUs granted to non-executive directors vest one year from the date of grant.

Performance share units (“PSUs”)

The following table summarizes the PSUs activity for the six months ended June 30, 2021:


	PSU
		Weighted average
	Number of	grant-date fair
	ordinary shares	value
Non-vested at December 31, 2020	212,614	$	42.32
Vested	(132,368)	$	33.09
Forfeited	(2,916)	$	57.56
Non-vested at June 30, 2021	77,330	$	57.56

The PSUs will vest on the third anniversary of the grant, subject to the grantee’s continued employment.

Employee Share Purchase Plan (“ESPP”)

In June 2018, the Company’s shareholders adopted and approved an ESPP allowing the Company to issue up to 150,000 ordinary shares. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code of 1986. Under the ESPP, employees are eligible to purchase ordinary shares through payroll deductions, subject to any plan limitations. The purchase price of the ordinary shares on each purchase date is equal to 85% of the lower of the closing market price on the offering date and the closing market price on the purchase date of each three-month offering period. During the six months ended June 30, 2021, 1,174 ordinary shares were issued under the ESPP compared to 3,005 during the same period in 2020. As of June 30, 2021, a total of 130,852 ordinary shares remain available for issuance under the ESPP plan compared to a total of 135,202 as of June 30, 2020.